As an observational study, there are likely sources of bias associated with anti-IL-23 treatment that were not captured or adjusted for in our analysis such as time-varying factors or a higher incidence of diabetes among non-anti-IL-23 patients. The gene discussed is IL37; the disease is diabetes mellitus.